Seroconversion in patients with acute hepatitis B reinfection after liver transplantation with a combined treatment of lamivudine and hepatitis B immune globulin.
Karliova
M
M
Department of Gastroenterology, University Hospital Essen, Essen, Germany.
Malago
M
M
Trippler
M
M
Valentin-Gamazo
C
C
Rothaar
T
T
Broelsch
C E
CE
Gerken
G
G
Treichel
U
U
D000208:Acute Disease; D000328:Adult; D001483:Base Sequence; D017931:DNA Primers; D004279:DNA, Viral / Q000097:blood; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006515:Hepatitis B virus / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use*; D008099:Liver / Q000821:virology; D016031:Liver Transplantation / Q000009:adverse effects* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction / Q000379:methods; D012008:Recurrence; D012189:Retrospective Studies; D013997:Time Factors
D017931:DNA Primers; D004279:DNA, Viral; D006514:Hepatitis B Surface Antigens; D007136:Immunoglobulins; D019259:Lamivudine; C045213:hepatitis B hyperimmune globulin